Circulating Biomarkers in Glioblastoma Ready for Prime Time?

被引：7

作者：

Mathios, Dimitrios ^{[1
]}

Phallen, Jillian ^{[2
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21287 USA

[2] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Koch Canc Res Bldg,1550 Orleans St,CRB2,Room 532, Baltimore, MD 21287 USA

来源：

CANCER JOURNAL | 2021年 / 27卷 / 05期

关键词：

Circulating biomarker; circulating RNAs; circulating tumor cells; circulating tumor DNA; glioblastoma; liquid biopsy; BRAIN-TUMOR CELLS; MICRORNA SIGNATURE; LIQUID BIOPSIES; DNA; GLIOMA; TEMOZOLOMIDE; MUTATION; BLOOD;

D O I：

10.1097/PPO.0000000000000541

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Liquid biopsy approaches for detection of circulating biomarkers of cancer have been utilized in oncology in many clinical settings from early detection to disease monitoring. Recent approaches have focused on circulating tumor cells, circulating tumor DNA, and circulating RNAs in a variety of biofluids. However, very little progress has been made in implementing such approaches for detection of brain tumors, despite the tremendous clinical need for earlier and less invasive diagnosis, as well as more accurate assessment of disease status. In this review, we highlight the recent methodological improvements in the field of liquid biopsy technologies specifically for glioblastoma. Although many retrospective and few prospective studies have been conducted to assess the utility of circulating biomarkers for detection of brain tumors, none have yet moved forward to clinical implementation.

引用

页码：404 / 409

页数：6

共 50 条

[41] Potential of circulating biomarkers in liquid biopsy diagnostics [J].

Yeo, Joo Chuan ;

Lim, Chwee Teck .

BIOTECHNIQUES, 2018, 65 (04) :187-189

[42] Tumor-Derived Biomarkers in Liquid Biopsy of Glioblastoma [J].

Khristov, Vladimir ;

Lin, Andrea ;

Freedman, Zachary ;

Staub, Jacob ;

Shenoy, Ganesh ;

Mrowczynski, Oliver ;

Rizk, Elias ;

Zacharia, Brad ;

Connor, James .

WORLD NEUROSURGERY, 2023, 170 :182-194

[43] Circulating biomarkers for gliomas [J].

Westphal, Manfred ;

Lamszus, Katrin .

NATURE REVIEWS NEUROLOGY, 2015, 11 (10) :556-566

[44] Circulating glioma biomarkers [J].

Kros, Johan M. ;

Mustafa, Dana M. ;

Dekker, Lennard J. M. ;

Smitt, Peter A. E. Sillevis ;

Luider, Theo M. ;

Zheng, Ping-Pin .

NEURO-ONCOLOGY, 2015, 17 (03) :343-360

[45] Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients? [J].

Hofman, P. ;

Heeke, S. ;

Alix-Panabieres, C. ;

Pantel, K. .

ANNALS OF ONCOLOGY, 2019, 30 (09) :1448-1459

[46] Circulating miR-26a and miR-21 as biomarkers for glioblastoma multiform [J].

ParvizHamidi, Monireh ;

Haddad, Ghazal ;

Ostadrahimi, Shiva ;

Ostadrahimi, Nima ;

Sadeghi, Sedigheh ;

Fayaz, Shima ;

Fard-Esfahani, Pezhman .

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2019, 66 (02) :261-265

[47] miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma [J].

D'Urso, Pietro Ivo ;

D'Urso, Oscar Fernando ;

Gianfreda, Cosimo Damiano ;

Mezzolla, Valeria ;

Storelli, Carlo ;

Marsigliante, Santo .

CURRENT GENOMICS, 2015, 16 (05) :304-311

[48] Next generation sequencing of glioblastoma circulating tumor cells: non-invasive solution for disease monitoring [J].

Kolostova, Katarina ;

Pospisilova, Eliska ;

Pavlickova, Vladimira ;

Bartos, Robert ;

Sames, Martin ;

Pawlak, Ireneusz ;

Bobek, Vladimir .

AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (05) :4489-4499

[49] Circulating biomarkers to guide systemic therapy for urothelial carcinoma [J].

Abbosh, Philip H. ;

Rosenberg, Jonathan E. ;

Plimack, Elizabeth R. .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (11) :502-509

[50] Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma [J].

Li, Mingdong ;

Long, Shengrong ;

Hu, Jinqu ;

Wang, Zan ;

Geng, Chao ;

Ou, Shaowu .

AGING-US, 2019, 11 (21) :9405-9423

← 1 2 3 4 5 →